FrancophonIA/ELRC3.0 huggingface dataset:
English: Co-administration of sufentanil with a serotonergic agent, such as Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine Reuptake Inhibitors (SNRIs), or Monoamine Oxidase Inhibitors (MAOIs), may increase the risk of serotonin syndrome, a potentially life threatening condition.
Croatian: Istodobna primjena sufentanila sa serotoninergičkim lijekovima, poput selektivnih inhibitora ponovne pohrane serotonina (SSRI), inhibitora ponovne pohrane serotonina i noradrenalina (SNRI) ili inhibitora monoaminooksidaze (MAOI), može povećati rizik od serotoninskog sindroma, stanja potencijalno opasnog po život.
English: Others
Croatian: Ostali
English: - Medicines for the treatment of depression known as Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs).
Croatian: - Lijekove za liječenje depresije koji se zovu selektivni inhibitori ponovne pohrane serotonina (SSRIs) i inhibitori ponovne pohrane serotonina i noradrenalina (SNRIs).
English: - Headache, drowsiness, feeling sleepy.
Croatian: - Glavobolja, omamljenost, osjećaj pospanosti.
English: Blood pressure increased Respiratory rate decreased Blood glucose increased Blood bilirubin increased Urine output decreased Aspartate aminotransferase increased
Croatian: Povišena razina bilirubina u krvi Smanjeno izlučivanje urina Povišena razina aspartat aminotransferaze Povišena razina ureje u krvi
English: Angina pectoris Atrial fibrillation
Croatian: Bradikardija Angina pektoris Atrijalna fibrilacija Ventrikularne ekstrasistole
English: Patients with moderate to severe hepatic or severe renal impairment should be monitored carefully for symptoms of sufentanil overdose (see section 4.9).
Croatian: Bolesnike s umjerenim do teškim oštećenjem funkcije jetre ili teškim oštećenjem funkcije bubrega treba pažljivo pratiti zbog simptoma predoziranja sufentanilom (vidjeti dio 4.9.).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING POUCH
Croatian: PODATCI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VREĆICA
English: Very common side effects (may affect more than 1 in 10 people): Nausea or feeling sick, vomiting or being sick and generally feeling hot.
Croatian: Vrlo česte nuspojave (mogu se pojaviti u više od 1 na 10 osoba): Mučnina, povraćanje i općeniti osjećaj vrućine.
English: Secondary pharmacodynamics effects
Croatian: Sekundarni farmakodinamički učinci
English: The symptoms of overdose include severe breathing problems like slow and shallow breathing, loss of consciousness, extremely low blood pressure, collapse and muscle rigidity.
Croatian: Ako primijenite više lijeka Dzuveo nego što ste trebali Simptomi predoziranja uključuju teške probleme s disanjem kao što su sporo i plitko disanje, gubitak svijesti, izrazito nizak krvni tlak, kolaps i krutost mišića.
English: Dzuveo is to be administered by a healthcare professional in a medically monitored setting only.
Croatian: Dzuveo treba davati zdravstveni radnik isključivo u okruženju koje je pod liječničkim nadzorom.
English: 5 x 1 sublingual tablet in a single dose applicator.
Croatian: 5 x 1 sublingvalna tableta u aplikatoru za jednu dozu.
English: Patients with a higher pain intensity at one hour after sufentanil treatment was initiated required more frequent redosing compared to patients with lower pain intensity scores at one hour.
Croatian: U bolesnika s većim intenzitetom boli jedan sat nakon početka liječenja sufentanilom bilo je potrebno češće ponovno doziranje u usporedbi s bolesnicima s nižim intenzitetom boli nakon jednog sata.
English: Sufentanil is mainly metabolised in humans by the cytochrome P450-3A4 enzyme system (see section 4.5).
Croatian: Sufentanil se u ljudi uglavnom metabolizira enzimskim sustavom citokrom P450-3A4 (vidjeti dio 4.5.).
English: Patients using Dzuveo had a mean SPID12 score that was superior to patients using placebo (25.8 vs. 13.1) in abdominal surgery patients (p<0.001) and (5.93 vs. -6.7) in bunionectomy patients (p=0.005) respectively.
Croatian: Bolesnici koji su uzimali Dzuveo imali su srednju vrijednost SPID12 rezultata višu od one u bolesnika koji su uzimali placebo (25,8 u usporedbi s 13,1) u bolesnika s operacijom abdomena (p < 0,001) i (5,93 u usporedbi s -6,7) u bolesnika s operacijom čukljeva (p = 0,005).
English: The applicator, with the tablet inside, is enclosed within a pouch.
Croatian: Aplikator s tabletom nalazi se u vrećici.
English: Gastrointestinal effects of sufentanil comprise decreased propulsive motility, reduced secretion and increased muscle tone (up to spasms) of the sphincters of the gastrointestinal tract (see section 4.4).
Croatian: Gastrointestinalni učinci sufentanila uključuju smanjenu propulzivnu pokretljivost, smanjenu sekreciju i povećani tonus mišića (sve do grčenja) sfinktera gastrointestinalnog trakta (vidjeti dio
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each sublingual tablet contains 30 micrograms of sufentanil (as citrate).
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Jedna sublingvalna tableta sadrži 30 mikrograma sufentanila (u obliku citrata).
English: Based on the population pharmacokinetic analysis for Dzuveo, hepatic function was not identified as a significant covariate for clearance.
Croatian: Na temelju analize populacijske farmakokinetike za Dzuveo, funkcija jetre nije zabilježena kao značajna kovarijata za klirens.
English: When ready to administer the medicine, tear open the slit-notched pouch across the top.
Croatian: Kada ste spremni za primjenu lijeka, otrgnite vrh vrećice s prorezom.
English: - Vision disturbances, eye pain.
Croatian: - Poremećaji vida, bol oka.
English: Sufentanil acts as a full agonist in μ-opioid receptors.
Croatian: Sufentanil djeluje kao potpuni agonist μ-opioidnih receptora.
English: Patients with a higher pain intensity at one hour after Dzuveo treatment was initiated required more frequent redosing compared to patients with lower pain intensity scores at one hour.
Croatian: U bolesnika s većim intenzitetom boli jedan sat nakon početka liječenja lijekom Dzuveo, bilo je potrebno češće ponovno doziranje u usporedbi s bolesnicima s nižim vrijednostima intenziteta boli nakon jednog sata.
English: The maximum daily dose is 720 micrograms (24 tablets per day).
Croatian: mikrograma (24 tablete na dan).
English: Procedural nausea Postoperative ileus Procedural vomiting Gastrointestinal stoma complication Procedural pain
Croatian: Mučnina tijekom postupka Postoperativni ileus Povraćanje tijekom postupka Komplikacija gastrointestinalne stome Bol tijekom postupka
English: Therefore, sufentanil should be used with caution in patients at risk of ileus.
Croatian: Stoga se savjetuje oprez pri primjeni sufentanila u bolesnika s rizikom od ileusa.
English: Sufentanil has potential for abuse.
Croatian: Postoji mogućnost zloupotrebe sufentanila.
English: Keep this medicine out of the sight and reach of children.
Croatian: Kako čuvati Dzuveo Lijek čuvajte izvan pogleda i dohvata djece.
English: - If you have any further questions, ask your doctor or pharmacist or nurse.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: - Dry mouth, flatulence (passing wind), constipation, indigestion or reflux.
Croatian: - Suha usta, flatulencija (puštanje vjetrova), zatvor, probavne smetnje ili refluks.
English: Significant respiratory depression or pulmonary compromise.
Croatian: Znatna respiratorna depresija ili smanjenje funkcije pluća.
English: Sufentanil is primarily metabolised by the human cytochrome P450-3A4 enzyme.
Croatian: Sufentanil se prvenstveno metabolizira humanim enzimom citokrom P450-3A4.
English: These medicines must not be taken in the 2 weeks before or at the same time as Dzuveo is given.
Croatian: Ti se lijekovi ne smiju uzimati dva tjedna prije početka uzimanja lijeka Dzuveo ni tijekom uzimanja lijeka Dzuveo.
English: Sublingual use To be used only with the single-dose applicator.
Croatian: Sublingvalna primjena Isključivo za upotrebu s aplikatorom za jednu dozu.
English: You can also report side effects directly via the national reporting system listed in
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava navedenog u Dodatku V.
English: Onset of analgesia, as measured by pain intensity difference to baseline scores, was greater (p<0.05) for sufentanil versus placebo by 15 minutes after the first dose in the abdominal study and 30 minutes in the bunionectomy study.
Croatian: Početak analgezije, mjeren razlikom intenziteta boli u usporedbi s početnim vrijednostima, bio je brži (p < 0,05) za sufentanil u odnosu na placebo za 15 minuta nakon prve doze u ispitivanju operacije abdomena i 30 minuta u ispitivanju operacije čukljeva.
English: Sufentanil as a μ-opioid receptor agonist may cause spasm of the sphincter of Oddi.
Croatian: Sufentanil kao agonist μ-opioidnih receptora može uzrokovati grčenje Oddijeva sfinktera.
English: Sufentanil as a μ-opioid receptor agonist may slow the gastrointestinal motility.
Croatian: Sufentanil kao agonist μ-opioidnih receptora može usporiti gastrointestinalnu pokretljivost.
English: exaggeration of reflex responses, burning sensation, feeling faint, abnormal sensation of the skin
Croatian: pretjeranost refleksnih reakcija, peckanje, osjećaj slabosti, neuobičajen osjećaj na koži (trnci,
English: 10 x 1sublingual tablet in a single-dose applicator.
Croatian: 10 x 1 sublingvalna tableta u aplikatoru za jednu dozu.
English: Therefore, sufentanil should be used with caution in patients with biliary tract disease, including acute pancreatitis.
Croatian: Stoga se savjetuje oprez pri primjeni sufentanila u bolesnika s bolešću žučnog trakta, uključujući akutni pankreatitis.
English: Grounds for the variation to the terms of the marketing authorisation(s) On the basis of the scientific conclusions for sufentanil the CHMP is of the opinion that the benefitrisk balance of the medicinal product(s) containing sufentanil is unchanged subject to the proposed changes to the product information
Croatian: Na temelju znanstvenih zaključaka za sufentanil, CHMP smatra da je omjer koristi i rizika lijeka(ova) koji sadrži(e) sufentanil nepromijenjen, uz predložene izmjene informacija o lijeku.
English: Bronchitis Conjunctivitis infective Pharyngitis
Croatian: Infektivni konjunktivitis Faringitis
English: Instructions for use of Single Dose Applicator (SDA) Single-Use Product / Do Not Reuse.
Croatian: Sljedeće informacije namijenjene su samo zdravstvenim radnicima: Upute za upotrebu aplikatora za jednu dozu Proizvod za jednokratnu upotrebu / nemojte ponovno upotrebljavati.
English: Hypomagnesaemia Hypoproteinaemia Hyperkalaemia Diabetes mellitus Hyperglycaemia Hyperlipidaemia Hypophosphataemia Hypovolaemia
Croatian: Hipomagnezijemija Hipoproteinemija Hiperkalemija Šećerna bolest Hiperglikemija Hiperlipidemija Hipofosfatemija Hipovolemija
English: In the abdominal surgery trial, mean baseline pain intensity was 5.61 (0.13) for sufentanil-treated patients and 5.48 (0.18) for placebo-treated patients.
Croatian: U ispitivanju operacije abdomena, srednja vrijednost početnog intenziteta boli bila je 5,61 (0,13) u bolesnika liječenih sufentanilom i 5,48 (0,18) u bolesnika koji su primali placebo.
English: As Dzuveo may affect your breathing, your doctor or nurse will check your breathing during treatment; - Have a head injury or brain tumour; - Have problems with your heart and circulation, especially slow heart rate, irregular heartbeat,
Croatian: S obzirom na to da Dzuveo može utjecati na disanje, vaš liječnik ili medicinska sestra provjeravat će vaše disanje tijekom liječenja; - ste imali ozljedu glave ili tumor na mozgu; - imate problema sa srcem i cirkulacijom, posebice usporenim radom srca, nepravilnim otkucajima srca, niskim volumenom krvi ili niskim krvim tlakom; - imate umjerene do teške probleme s jetrom ili teške probleme s bubrezima, jer ti organi utječu na način na koji vaše tijelo razgrađuje i eliminira lijek; ili ako imate neuobičajeno sporu probavu; - bolujete od bolesti žučnog mjehura ili gušterače; - imate povijest prekomjerne konzumacije lijekova ili alkohola.
English: Sufentanil should be administered with caution to patients with moderate to severe hepatic or severe renal impairment (see section 4.4).
Croatian: Sufentanil treba davati oprezno bolesnicima s umjerenim do teškim oštećenjem funkcije bubrega ili jetre (vidjeti dio 4.4.).
English: Uncommon side effects (may affect up to 1 in 100 people): - Inflammation of the lungs, eye redness and inflammation, inflammation of the throat.
Croatian: Manje česte nuspojave (mogu zahvatiti do 1 na 100 osoba): - Upala pluća, crvenilo i upala očiju, upala grla.
English: Hypoaesthesia oral
Croatian: Oralna hipoestezija
English: - Chest pain and breathing difficulties caused by a blood clot in lung, fluid in the lungs, wheezing.
Croatian: - Bol u prsnom košu i poteškoće s disanjem uzrokovane krvnim ugruškom u plućima, tekućina u plućima, piskanje pri disanju.
English: Primary pharmacodynamics effects
Croatian: Primarni farmakodinamički učinci
English: Steady-state clearance is 129.3 L/hr.
Croatian: Klirens u stanju dinamičke ravnoteže je 129,3 l/h.
English: Do Not Use if Pouch Seal is Broken
Croatian: Ne upotrebljavajte ako je vrećica oštećena
English: If you experience any of the above mentioned side effects, tell your doctor or nurse immediately.
Croatian: Ako osjetite bilo koju od prethodno navedenih nuspojava, odmah obavijestite liječnika ili medicinsku sestru.
English: Tachycardia Sinus tachycardia
Croatian: Tahikardija Sinusna tahikardija
English: If these start to develop, tell a doctor or nurse immediately.
Croatian: Ako se počnu pojavljivati ti simptomi, odmah obavijestite liječnika ili medicinsku sestru.
English: The pouch contains one clear plastic SDA with a single blue-coloured tablet housed in the tip, and an oxygen absorber packet.
Croatian: Vrećica sadržava jedan prozirni plastični aplikator za jednu dozu s jednom tabletom plave boje na vrhu i paketom apsorbera kisika.
English: Constipation Dyspepsia Flatulence Dry Mouth
Croatian: Zatvor Dispepsija Nadutost Suha usta
English: Mean (SEM) baseline intensity in these trials was 6.48 (0.21) for the 12-hour bunionectomy trial in the sufenatil-treated patients and 5.98 (0.30) for placebo-treated patients.
Croatian: Srednja vrijednost (standardna pogreška) početnog intenziteta u ovim ispitivanjima bila je 6,48 (0,21) za 12-satno ispitivanje operacije čukljeva u bolesnika liječenih sufentanilom i 5,98 (0,30) u bolesnika koji su primali placebo.
English: A population pharmacokinetic analysis of plasma sufentanil concentrations following usage of Dzuveo did not identify renal function as a significant covariate for clearance.
Croatian: Analizom populacijske farmakokinetike provedenom na koncentraciji sufentanila u plazmi nakon primjene lijeka Dzuveo bubrežna funkcija nije zabilježena kao značajna kovarijata za klirens.
English: (tingling, skin crawling), numbness in general, tiredness, forgetfulness, migraine, tension headaches.
Croatian: naježena koža), ukočenost općenito, umor, zaboravljivost, migrena, tenzijske glavobolje.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SINGLE-DOSE APPLICATOR
Croatian: OSNOVNI PODATCI KOJI SE MORAJU NALAZITI NA MALIM UNUTARNJIM PAKIRANJIMA
English: Lipoma
Croatian: Lipom
English: - Ketoconazole, which is used for the treatment of fungal infections this medicine may have an effect on the way in which your body breaks down sufentanil.
Croatian: Posebice obavijestite svog liječnika ako uzimate bilo što od navedenog u nastavku: - Ketokonazol, koji se upotrebljava za liječenje gljivičnih infekcija, može utjecati na način na koji vaše tijelo razgrađuje sufentanil.
English: Each sublingual tablet contains 30 micrograms sufentanil (as citrate).
Croatian: Jedna sublingvalna tableta sadržava 30 mikrograma sufentanila (u obliku citrata).
English: Sufentanil should be used with caution in patients with brain tumours.
Croatian: Savjetuje se oprez pri primjeni sufentanila u bolesnika s tumorima mozga.
English: Anaphylactic shock
Croatian: Anafilaktički šok
English: - Difficulty urinating, strong smelling urine, pain urinating, kidney failure.
Croatian: - Poteškoće pri mokrenju, urin jakog mirisa, bol pri mokrenju, zatajenje bubrega.
English: Headache Dizziness Somnolence Sedation
Croatian: Glavobolja Omaglica Somnolencija Sedacija
English: - Muscle twitching and spasms.
Croatian: - Trzanje i grčevi mišića.
English: Central nervous system (CNS) depressants
Croatian: Depresori središnjeg živčanog sustava
English: Tension headache
Croatian: Migrena Tenzijska glavobolja
English: The sublingual tablet will be given to you by a healthcare professional using the disposable single-dose applicator.
Croatian: Zdravstveni radnik dat će vam sublingvalnu tabletu koristeći se jednokratnim aplikatorom za jednu dozu.
English: 6.6 Special precautions for disposal and other handling Instructions for use of Single Dose Applicator (SDA) Single-Use Product / Do Not Reuse
Croatian: 6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Upute za upotrebu aplikatora za jednu dozu
English: Marketing Authorisation Holder FGK Representative Service GmbH, Heimeranstr.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet FGK Representative Service GmbH, Heimeranstr.
English: Calcium hydrogen phosphate Hypromellose Croscarmellose sodium Indigo carmine -E132 Stearic acid
Croatian: Manitol - E421 Kalcijev hidrogenfosfat Hipromeloza Karmelozanatrij, umrežena Boja indigo carmine - E132 Stearinska kiselina Magnezijev stearat 6.2 Inkompatibilnosti
English: ≥1/10,000 to
Croatian: Vrlo rijetko < 1/10 000
English: Do Not Use if Pouch Seal is Broken.
Croatian: Ne upotrebljavajte ako je vrećica oštećena.
English: What Dzuveo looks like and contents of the pack Dzuveo is a blue-coloured, flat-faced sublingual tablet with round edges.
Croatian: Dzuveo je plosnata sublingvalna tableta plave boje sa zaobljenim rubovima.
English: NOTE: Avoid direct mucosal contact with the SDA tip.
Croatian: NAPOMENA: izbjegavajte izravan dodir sluznice s vrhom aplikatora za jednu dozu.
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to special and restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Croatian: Lijek se izdaje na poseban i ograničeni recept (vidjeti Prilog I.: Sažetak opisa svojstava lijeka, dio
English: What you need to know before you use Dzuveo Do not use Dzuveo:
Croatian: Što morate znati prije nego što počnete uzimati Dzuveo 3.
English: Dzuveo passes into breast milk and can cause side effects in the breast-fed child. Breastfeeding is not recommended while you are taking Dzuveo.
Croatian: Dzuveo se izlučuje u majčino mlijeko i može uzrokovati nuspojave u dojenog djeteta.
English: Respiratory arrest
Croatian: Respiratorni zastoj
English: Tremor Ataxia Dystonia Hyperreflexia Tremor Burning sensation Presyncope Paraesthesia Hypoaesthesia Lethargy Memory impairment Migraine
Croatian: Tremor Ataksija Distonija Hiperrefleksija Tremor Peckanje Presinkopa Parestezija Hipoestezija
English: Feeling hot Fatigue Asthenia Chills Local swelling Non-cardiac chest pain Chest discomfort
Croatian: Osjećaj vrućine Umor Astenija Zimica Lokalno oticanje Nekardijalna bol u prsnom košu Nelagoda u prsnom košu
English: NAME OF THE MEDICINAL PRODUCT Dzuveo 30 micrograms sublingual tablet
Croatian: NAZIV LIJEKA Dzuveo 30 mikrograma sublingvalna tableta
English: Abdominal discomfort Abdominal distension Abdominal Pain upper Epigastric discomfort Gastritis
Croatian: Nagon na povraćanje Nelagoda u abdomenu Distenzija abdomena Bol u gornjem dijelu abdomena Epigastrična nelagoda Gastritis Bolest gastroezofagealnog refluksa
English: Diastolic hypotension Orthostatic hypotension
Croatian: Ortostatska hipertenzija Navala crvenila Dijastolička hipotenzija Ortostatska hipotenzija
English: Hypoxia
Croatian: Hipoventilacija
English: Hyperhidrosis Hypoaesthesia facial Pruritus generalized Blister
Croatian: Hiperhidroza Hipoestezija lica Generalizirani pruritus Plikovi Osip Suha koža
English: Impaired hepatic or renal function
Croatian: Oštećenje funkcije bubrega ili jetre
English: There are no or limited amount of data from the use of sufentanil in pregnant women.
Croatian: Ne postoje podatci o primjeni sufentanila u trudnica ili je njihova količina ograničena.
English: Anaemia Leukocytosis
Croatian: Anemija Leukocitoza Trombocitopenija
English: Musculoskeletal pain Musculoskeletal chest pain
Croatian: Mišićni grčevi Trzanje mišića
English: - Diarrhoea, burping or belching, inflammation of stomach lining or gastritis, bloating, acid reflux,
Croatian: - Proljev, podrigivanje, upala želučane sluznice ili gastritis, nadutost, refluks kiseline, nagon na povraćanje, bol u želucu ili neugoda u želucu.
English: Dzuveo 30 micrograms sublingual tablets sufentanil
Croatian: Dzuveo 30 mikrograma sublingvalne tablete sufentanil
English: Dzuveo 30 mcg sublingual tablet sufentanil
Croatian: Dzuveo 30 μg sublingvalna tableta sufentanil
English: Eye pain Visual disturbance
Croatian: Bol oka Poremećaj vida Mioza
English: - If you are allergic to sufentanil or any of the other ingredients of this medicine (listed in section
Croatian: Što morate znati prije nego što počnete uzimati Dzuveo Nemojte uzimati Dzuveo: - ako ste alergični na sufentanil ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.); - ako imate ozbiljan problem s plućima ili disanjem.
English: Dzuveo 30 micrograms sublingual tablet sufentanil
Croatian: Dzuveo 30 mikrograma sublingvalna tableta sufentanil
English: - If you get any side effects, talk to your doctor, or pharmacist or nurse.
Croatian: - Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, ljekarnika ili medicinsku sestru.
English: Oxygen saturation decreased Body temperature increased
Croatian: Povišena tjelesna temperatura
English: Hypocalcaemia Hypoalbuminaemia Hypokalaemia Hyponatraemia
Croatian: Hipokalcemija Hipoalbuminemija Hipokalemija
English: Hepatic enzyme increased Liver function test abnormal
Croatian: Abnormalni pokazatelji funkcije jetre
English: Some insoluble excipients of the tablet may remain in the mouth after dissolution is complete; this is normal and does not indicate lack of absorption of sufentanil from the tablet.
Croatian: Neke netopljive pomoćne tvari u tableti mogu ostati u ustima nakon što se otapanje dovrši.
English: Pusher
Croatian: Potisnik
English: Rash Dry Skin
Croatian: crvenilo kože.
English: Fax:
Croatian: E-pošta:
English: Withdrawal syndrome which may include symptoms such as agitation, anxiety, muscle aches, insomnia, sweating and yawning.
Croatian: tjeskoba, bolovi u mišićima, nesanica, znojenje i zijevanje.
English: Bradypnoea Epistaxis Hiccups Apnoea Atelectasis Hypoventilation Pulmonary embolism Pulmonary oedema Respiratory distress Respiratory failure Wheezing
Croatian: Bradipneja Epistaksa Štucanje Apneja Atelektaza
English: Posology
Croatian: Telefon:
English: However, due to the limited number of patients with severe renal impairment studied, Dzuveo should be used with caution in such patients (see section 4.4).
Croatian: Međutim, zbog ograničenog broja bolesnika s teškim oštećenjem funkcije bubrega koji su ispitivani, u tih bolesnika
English: Erythema
Croatian: Živčanost
English: STATEMENT OF ACTIVE SUBSTANCE(S)
Croatian: Sindrom ustezanja (apstinencijske krize)
English: Discard the Lock.
Croatian: Bacite graničnik.
English: Annex IV Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Croatian: PRILOG IV. ZNANSTVENI ZAKLJUČCI
English: Elderly
Croatian: Eritem
English: The areas should be left to dry out before applying other creams or cosmetics.
Croatian: Područja se moraju osušiti prije nanošenja drugih krema ili kozmetičkih proizvoda.
English: Mirvaso should not be used in children or adolescents aged from 2 to 18 years.
Croatian: Mirvaso se ne smije koristiti u djece ili adolescenata u dobi od 2 do 18 godina.
English: This summary was last updated in 02-2014.
Croatian: Sažetak je posljednji put ažuriran 02.2014.
English: Mirvaso brimonidine
Croatian: Mirvaso brimonidin
English: Mirvaso should only be applied to the skin of the face.
Croatian: Mirvaso se treba nanositi samo na kožu lica.